Vista Pharmaceuticals Limited (VISTAPH.BO)
INR 11.08
(2.12%)
INR 11.08
(2.12%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 20.16 Million INR | 87.78% |
| 2022 | 16.9 Million INR | 5.0% |
| 2021 | 16.09 Million INR | -45.47% |
| 2020 | 29.52 Million INR | -36.85% |
| 2019 | 46.74 Million INR | -6.73% |
| 2018 | 50.12 Million INR | -8.05% |
| 2017 | 54.5 Million INR | 9.03% |
| 2016 | 49.99 Million INR | 69.42% |
| 2015 | 29.5 Million INR | -6.43% |
| 2014 | 31.53 Million INR | 59.25% |
| 2013 | 19.8 Million INR | -3.98% |
| 2012 | 20.62 Million INR | 12.3% |
| 2011 | 18.36 Million INR | 16.02% |
| 2010 | 15.82 Million INR | -4.98% |
| 2009 | 16.65 Million INR | -2.03% |
| 2008 | 17 Million INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 5.19 Million INR | -49.56% |
| 2023 Q3 | 7.69 Million INR | -52.27% |
| 2023 FY | 31.74 Million INR | 87.78% |
| 2023 Q4 | 8.91 Million INR | 15.82% |
| 2023 Q2 | 16.12 Million INR | 45.76% |
| 2023 Q1 | 11.06 Million INR | 103.51% |
| 2022 Q3 | 4.88 Million INR | 61.59% |
| 2022 FY | 16.9 Million INR | 5.0% |
| 2022 Q4 | 5.43 Million INR | 11.21% |
| 2022 Q2 | 3.02 Million INR | -14.91% |
| 2022 Q1 | 3.55 Million INR | -18.43% |
| 2021 Q2 | 4.8 Million INR | -16.94% |
| 2021 FY | 16.09 Million INR | -45.47% |
| 2021 Q4 | 4.35 Million INR | 35.22% |
| 2021 Q1 | 5.78 Million INR | -50.91% |
| 2021 Q3 | 3.22 Million INR | -32.91% |
| 2020 Q4 | 11.78 Million INR | 68.07% |
| 2020 FY | 29.52 Million INR | -36.85% |
| 2020 Q1 | 2.87 Million INR | -27.86% |
| 2020 Q2 | 7.85 Million INR | 172.99% |
| 2020 Q3 | 7.01 Million INR | -10.75% |
| 2019 Q3 | 7.89 Million INR | -17.79% |
| 2019 Q4 | 3.98 Million INR | -49.51% |
| 2019 FY | 46.74 Million INR | -6.73% |
| 2019 Q1 | 21.75 Million INR | 385.77% |
| 2019 Q2 | 9.6 Million INR | -55.84% |
| 2018 Q4 | 4.47 Million INR | -51.84% |
| 2018 FY | 50.12 Million INR | -8.05% |
| 2018 Q2 | 17.99 Million INR | -1.95% |
| 2018 Q1 | 18.35 Million INR | -3.89% |
| 2018 Q3 | 9.29 Million INR | -48.32% |
| 2017 Q2 | 22.29 Million INR | 6.06% |
| 2017 FY | 54.5 Million INR | 9.03% |
| 2017 Q4 | 19.09 Million INR | -17.42% |
| 2017 Q3 | 23.12 Million INR | 3.7% |
| 2017 Q1 | 21.02 Million INR | 3.17% |
| 2016 Q1 | 12.81 Million INR | 45.6% |
| 2016 Q4 | 20.37 Million INR | 354.03% |
| 2016 Q3 | 4.48 Million INR | 1.06% |
| 2016 Q2 | 4.44 Million INR | -65.33% |
| 2016 FY | 49.99 Million INR | 69.42% |
| 2015 Q4 | 8.79 Million INR | 109.4% |
| 2015 FY | 29.5 Million INR | -6.43% |
| 2015 Q1 | 4.24 Million INR | 43.8% |
| 2015 Q2 | 4.2 Million INR | -0.99% |
| 2015 Q3 | 4.2 Million INR | 0.05% |
| 2014 Q4 | 2.94 Million INR | -19.18% |
| 2014 FY | 31.53 Million INR | 59.25% |
| 2014 Q1 | 7.12 Million INR | 9626.95% |
| 2014 Q2 | 8.16 Million INR | 14.7% |
| 2014 Q3 | 3.65 Million INR | -55.31% |
| 2013 Q1 | 6.93 Million INR | 482.02% |
| 2013 FY | 19.8 Million INR | -3.98% |
| 2013 Q4 | 73.2 Thousand INR | -98.67% |
| 2013 Q3 | 5.48 Million INR | -21.93% |
| 2013 Q2 | 7.02 Million INR | 1.37% |
| 2012 Q1 | 7.22 Million INR | 482.65% |
| 2012 FY | 20.62 Million INR | 12.3% |
| 2012 Q4 | -1.81 Million INR | -126.62% |
| 2012 Q3 | 6.81 Million INR | 17.21% |
| 2012 Q2 | 5.81 Million INR | -19.47% |
| 2011 FY | 18.36 Million INR | 16.02% |
| 2011 Q3 | 6.51 Million INR | 0.0% |
| 2011 Q4 | -1.88 Million INR | -128.97% |
| 2010 FY | 15.82 Million INR | -4.98% |
| 2010 Q4 | 5.69 Million INR | 0.0% |
| 2009 Q4 | 3.71 Million INR | 0.0% |
| 2009 FY | 16.65 Million INR | -2.03% |
| 2008 Q4 | 4.21 Million INR | 0.0% |
| 2008 FY | 17 Million INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| ANG Lifesciences India Limited | 219.92 Million INR | 90.831% |
| Add-Shop E-Retail Limited | 146.52 Million INR | 86.237% |
| Bacil Pharma Limited | 1.87 Million INR | -975.87% |
| Beryl Drugs Limited | 93.77 Million INR | 78.494% |
| Cian Healthcare Limited | 59.19 Million INR | 65.935% |
| Colinz Laboratories Limited | 31.19 Million INR | 35.361% |
| Concord Drugs Limited | 91.83 Million INR | 78.04% |
| Deccan Health Care Limited | 36.24 Million INR | 44.357% |
| Gennex Laboratories Limited | 130.37 Million INR | 84.533% |
| Gujarat Terce Laboratories Limited | 132.41 Million INR | 84.771% |
| Ishita Drugs and Industries Limited | 16.46 Million INR | -22.463% |
| Kerala Ayurveda Limited | 399.64 Million INR | 94.954% |
| Kwality Pharmaceuticals Limited | 248.93 Million INR | 91.899% |
| Mercury Laboratories Limited | 217.24 Million INR | 90.717% |
| Panchsheel Organics Limited | 68.15 Million INR | 70.413% |
| Parmax Pharma Limited | 99.31 Million INR | 79.695% |
| Parnax Lab Limited | 80.59 Million INR | 74.978% |
| Patidar Buildcon Limited | 1.81 Million INR | -1013.528% |
| Pharmaids Pharmaceuticals Limited | 76.49 Million INR | 73.637% |
| Phaarmasia Limited | 50.52 Million INR | 60.088% |
| Sandu Pharmaceuticals Limited | 212.9 Million INR | 90.528% |
| Sastasundar Ventures Limited | 846.78 Million INR | 97.619% |
| SHELTER PHARMA LIMITED | 12.3 Million INR | -63.945% |
| Source Natural Foods and Herbal Supplements Limited | 31.85 Million INR | 36.698% |
| SUDARSHAN PHARMA INDUSTRIES LI | 146.09 Million INR | 86.196% |
| Sunil Healthcare Limited | 438.1 Million INR | 95.397% |
| Syschem (India) Limited | 64.13 Million INR | 68.555% |
| Trident Lifeline Limited | 46.87 Million INR | 56.976% |
| Transchem Limited | 8.47 Million INR | -138.003% |
| Tyche Industries Limited | 182.04 Million INR | 88.922% |
| Vikram Thermo (India) Limited | 104.27 Million INR | 80.661% |
| Vasundhara Rasayans Limited | 145.5 Million INR | 86.141% |
| Zenith Healthcare Limited | 45.97 Million INR | 56.14% |
| Zenotech Laboratories Limited | 94.82 Million INR | 78.733% |
| Hindustan Bio Sciences Limited | 2.6 Million INR | -673.105% |
| KIMIA BIOSCIENCES LIMITED | 149.52 Million INR | 86.513% |
| Chemo Pharma Laboratories Limited | 1.94 Million INR | -935.747% |
| MedPlus Health Services Limited | 2.42 Billion INR | 99.168% |
| Sanjivani Paranteral Limited. | 208.87 Million INR | 90.346% |
| Smruthi Organics Limited | 261.73 Million INR | 92.295% |
| Trimurthi Limited | 4.81 Million INR | -319.164% |
| Zenlabs Ethica Limited | 57.89 Million INR | 65.168% |
| Makers Laboratories Limited | 83.1 Million INR | 75.734% |
| Lactose (India) Limited | 111.66 Million INR | 81.94% |
| Bharat Immunologicals & Biologicals Corporation Limited | 184.08 Million INR | 89.045% |
| Roopa Industries Limited | 24.63 Million INR | 18.141% |
| PANJON LTD. | 33.77 Million INR | 40.3% |
| TIAAN CONSUMER LIMITED | 107 Thousand INR | -18746.729% |
| Anuh Pharma Limited | 263.04 Million INR | 92.334% |
| Crestchem Limited | 50.8 Million INR | 60.305% |
| Emmessar Biotech & Nutrition Limited | 4.32 Million INR | -366.59% |
| PRAVEG LIMITED | 77.18 Million INR | 73.872% |
| Fredun Pharmaceuticals Limited | 360.45 Million INR | 94.405% |
| Shukra Pharmaceuticals Limited | 83.05 Million INR | 75.719% |
| Norris Medicines Limited | 18.2 Million INR | -10.771% |
| Denis Chem Lab Limited | 453.36 Million INR | 95.552% |
| Veerhealth Care Limited | 15.38 Million INR | -31.101% |
| Jenburkt Pharmaceuticals Limited | 437.2 Million INR | 95.388% |
| OXYGENTA PHARMACEUTICAL LIMITE | 23.78 Million INR | 15.198% |
| Godavari Drugs Limited | 359.01 Million INR | 94.383% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.52 Million INR | -1223.228% |
| Ambalal Sarabhai Enterprises Limited | 280.83 Million INR | 92.819% |
| Vivanza Biosciences Limited | 4.55 Million INR | -342.722% |
| Medi-Caps Limited | 93.11 Million INR | 78.344% |
| DECIPHER LABS LIMITED | 277.6 Million INR | 92.736% |
| Shree Ganesh Remedies Limited | 104.13 Million INR | 80.635% |
| Gujarat Themis Biosyn Limited | 156.84 Million INR | 87.143% |
| Bharat Parenterals Limited | 255.97 Million INR | 92.122% |
| BDH Industries Limited | 57.03 Million INR | 64.641% |
| Coral Laboratories Limited | 189.75 Million INR | 89.373% |
| Evoq Remedies Limited | 4.51 Million INR | -346.447% |
| Trinity League India Limited | -1.08 Million INR | 1956.906% |
| KOBO BIOTECH LIMITED | 2.48 Million INR | -713.145% |
| Natural Capsules Limited | 444.7 Million INR | 95.465% |
| Auro Laboratories Limited | 157.37 Million INR | 87.186% |